Thomas Jaki - MRC Biostatistics Unit

Research theme(s)

Sorry, but you do not have permission to view this content.

Jaki T, Burdon A, Chen X, Mozgunov P, Zheng H, Baird R (accepted)Early phase clinical trials in oncology: realising the potential of seamless designs
European Journal of Cancer :

Barnett H, Villar SS, Geys H, Jaki T. (2023)A Novel Statistical Test for Treatment Differences in Clinical Trials using a Response Adaptive Forward Looking Gittins Index Rule
Biometrics 79: (1):86-97

Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B., Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie K, Haynes R, Landray MJ. (2021)Effect of Dexamethasone in Hospitalized Patients with COVID-19
New England Journal of Medicine 384: 693-704

Burnett T, Mozgunov P, Pallmann P, Villar S, Wheeler G, Jaki T. (2020)Adding flexibility to clinical trials designs: an example-based guide to the practical use of adaptive designs
BMC Medicine 18: 352

Mozgunov P, Jaki T. (2020)An information-theoretic approach for selecting arms in clinical trials
Journal of the Royal Statistical Society - Series B. 82: 1223-1247